Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
UTI Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.22
1.99
NAV
₹371.11
₹573.55
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1429.84 Cr
₹5870.00 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
12.10%
14.92%
3 Year
20.77%
20.79%
5 Year
13.68%
16.17%
Equity
94.27%
96.79%
Cash
5.71%
3.16%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 8.25% |
Divi's Laboratories Ltd. | 6.21% |
Ajanta Pharma Ltd. | 4.74% |
Gland Pharma Ltd. | 3.70% |
Dr. Reddy's Laboratories Ltd. | 3.62% |
Alkem Laboratories Ltd. | 3.29% |
Apollo Hospitals Enterprise Ltd. | 3.27% |
Max Healthcare Institute Ltd. | 3.10% |
Lupin Ltd. | 3.09% |
Caplin Point Laboratories Ltd. | 3.05% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.33% |
Divi's Laboratories Ltd. | 8.17% |
Apollo Hospitals Enterprise Ltd. | 4.91% |
Acutaas Chemicals Ltd. | 4.91% |
Torrent Pharmaceuticals Ltd. | 4.72% |
Cipla Ltd. | 4.67% |
Max Healthcare Institute Ltd. | 4.31% |
Laurus Labs Ltd. | 3.96% |
Aurobindo Pharma Ltd. | 3.90% |
Aster DM Quality Care Ltd. | 3.52% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999
